Table 3.
Clinical and pathological parameters of CCRCC patients, and gender and age of patients with PRCC, ChRCC and RO.
| Tumour Subtype | CCRCC (n = 89) |
PRCC (n = 21) |
ChRCC (n = 8) |
RO (n = 8) |
|---|---|---|---|---|
| Age (range) | 61.4 (36–82) | 54.0 (26–80) | 64.6 (47–74) | 63.5 (40–84) |
| Sex (Male/Female) | 60/29 | 17/4 | 7/1 | 3/7 |
| Follow-up (months) | 59.9 (1–91) | |||
| Survival | ||||
| Alive | 68 | |||
| Dead of disease | 15 | |||
| Dead by other causes | 6 | |||
| Diameter | ||||
| ≤4 cm | 28 | |||
| >4 to 7cm | 39 | |||
| >7 cm | 22 | |||
| Fuhrman grade | ||||
| G1 | 3 | |||
| G2 | 46 | |||
| G3 | 30 | |||
| G4 | 10 | |||
| Local invasion (pT) | ||||
| pT1 | 59 | |||
| pT2 | 12 | |||
| pT3 | 16 | |||
| pT4 | 2 | |||
| Lymph node invasion (N) | ||||
| No | 83 | |||
| Yes | 6 | |||
| Distant metastasis (M) | ||||
| No | 66 | |||
| Synchronous | 10 | |||
| Metachronous | 13 |